# Dianthus Therapeutics, Inc.: Form 8-K, filed Sep 8, 2023

- Company: [Dianthus Therapeutics, Inc.](/companies/dnth.md) (CIK 1690585)
- Form: 8-K
- Filed: 2023-09-08
- Accepted by EDGAR: Sep 8, 2023, 17:19 ET
- Period: 2023-09-08
- Accession: 0001193125-23-231669
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1690585/000119312523231669/d515463d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1690585/000119312523231669/

## Items reported

- Item 5.07: Shareholder vote results
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1690585/000119312523231669/d515463d8k.htm

Filed Sep 8, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-231669. Last ingested by Listed: Nov 10, 2026, 03:21 ET. No prices; not investment advice.